Furthermore, in mouse mammary tumors, vaccination with tumor antigens (Otud6b, Pdhx or Stk39) induced tumor-specific CD4+ and CD8+ T cells, along with tumor-specific IFN-g T cell and CD8+ T cell responses. This evidence concerns the gene STK39 and neoplasm.